CLSI M23A2
$107.00
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2
CLSI M23A2 addresses the required and recommended data needed for the selection of appropriate interpretive standards and quality control guidelines for antimicrobial agents.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Related products
$79.00
$90.00
$90.00
$100.00
$85.00
$90.00
$90.00
$95.00